FDA NDC Directory · JSON-LD · Markdown

SUPPRELIN LA

NDC 67979-002 · HUMAN PRESCRIPTION DRUG · IMPLANT

Generic namehistrelin acetate
Labeler / ManufacturerEndo USA, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022058
Dosage form / routeIMPLANT · SUBCUTANEOUS
Active ingredientsHISTRELIN ACETATE (50 mg/1)
Marketing started20070531
Package count1

External sources

Source: openFDA. Public-domain (CC0).